Onderzoeker
Peter Bossuyt
- Disciplines:Endocrinologie en metabole ziekten, Gastro-enterologie en hepatologie, Ontdekking en evaluatie van biomarkers, Ontdekking en evaluatie van geneesmiddelen, Medicinale producten, Farmaceutica, Farmacognosie en fytochemie, Farmacologie, Farmacotherapie, Toxicologie en toxinologie, Andere farmaceutische wetenschappen
Affiliaties
- Translationeel Onderzoek van Gastro-enterologische Aandoeningen (TARGID) (Afdeling)
Lid
Vanaf1 jun 2015 → Heden
Publicaties
121 - 130 van 151
- SUPERIOR ENDOSCOPIC AND DEEP REMISSION OUTCOMES IN ADULTS WITH MODERATE TO SEVERE CROHN'S DISEASE MANAGED WITH TREAT TO TARGET APPROACH VERSUS CLINICAL SYMPTOMS: DATA FROM CALM(2017)
Auteurs: Jean Frederic Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukas, Filip J Baert, Tomas Vanasek, Ahmet Danalioglu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hebuterne, et al.
Pagina's: S155 - S155 - DISEASE COURSE AND OPERATIVE RISK AFTER DIAGNOSIS OF ILEAL PENETRATING CROHN'S DISEASE: A COHORT STUDY(2017)
Auteurs: Peter Bossuyt, Celine Debeuckelaere, Marc Ferrante, Anthony de Buck van Overstraeten, Thibo Billiet, Dirk Vanbeckevoort, Albert Wolthuis, André D'Hoore, Gert Van Assche, Séverine Vermeire
Pagina's: S1212 - S1212 - EARLY FIBROSTENOSIS IN CROHN'S DISEASE IS ASSOCIATED WITH MULTIPLE SUSCEPTIBILITY LOCI ON IMMUNOCHIP ANALYSIS(2017)
Auteurs: Tom Holvoet, Peter Bossuyt, Isabelle Cleynen, Isabelle De Kock, Pieter Hindryckx, Séverine Vermeire, Debby Laukens, Martine De Vos
Pagina's: S982 - S982 - Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases(2017)
Auteurs: Peter Bossuyt, Marc Ferrante
Pagina's: 333 - 340 - Primetime for e-health in IBD?(2017)
Auteurs: Peter Bossuyt
Pagina's: 133 - 134 - Disease course and operative risk after diagnosis of ileal penetrating Crohn's disease: a cohort study(2017)
Auteurs: Peter Bossuyt, C Debeuckelaere, Marc Ferrante, A De Buck van Overstraeten, T Billiet, D Vanbeckevoort, Albert Wolthuis, A D'Hoore, Gert Van Assche, Séverine Vermeire
Pagina's: S209 - S209 - Early fibrostenosis in Crohn's disease is associated with multiple susceptibility loci on Immunochip analysis(2017)
Auteurs: T Holvoet, Peter Bossuyt, Isabelle Cleynen, I De Kock, P Hindryckx, Séverine Vermeire, D Laukens, M De Vos
Pagina's: S54 - S55 - Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study(2017)
Auteurs: Uri Kopylov, Konstantinos Papamichael, Konstantinos Katsanos, Matti Waterman, Ariella Bar-Gil Shitrit, Trine Boysen, Francisco Portela, Armando Peixoto, Andrew Szilagyi, Marco Silva, et al.
Pagina's: 1605 - 1613 - Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO)(2017)
Auteurs: Lucas Wauters, Ilse Hoffman, Peter Bossuyt, Séverine Vermeire
Pagina's: 1584 - 1591 - Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study(2017)
Auteurs: Peter Bossuyt, Marc Ferrante, Séverine Vermeire
Pagina's: 1605 - 1613